Fig. 8

The impact of propofol in combination with cisplatin or doxorubicin on the protein expression in human ovarian cancer cells. (A) SKOV3 and (B) OVCAR3 cells treated with propofol at concentrations of 0 and 50 µg/ml, combined with either 10 µM cisplatin or 1 µM doxorubicin, for a duration of 24 h. Cell lysates were subjected to Western blot analysis using antibodies against the indicated proteins. α-tubulin was used as the loading control